MS
Mahesh Sambhaji Jadhav
About Mahesh Sambhaji Jadhav
Data last updated:
Mahesh Sambhaji Jadhav is a Designated Partner at J3 Cure Pharmaceuticals Llp (since 2020). The companies operate in Chemicals and Pharma. Earlier, Mahesh Sambhaji Jadhav was a Director at Cliniva Pharmaceuticals Private Limited (2019–2022).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Designated Partner | 29 Aug 2020 | 2020 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 17 Dec 2019 | 2019 | ₹1.45 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Mahesh Sambhaji Jadhav
| Name | DIN | Company | Designation |
|---|---|---|---|
| Prashant Govindbhai Desai | 08854730 | J3 Cure Pharmaceuticals Llp | Designated Partner |
| Sushant Jayshing Jawak | 08854731 | J3 Cure Pharmaceuticals Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mahesh Sambhaji Jadhav
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mahesh Sambhaji Jadhav
Mahesh Sambhaji Jadhav currently holds 1 directorship: J3 Cure Pharmaceuticals Llp (Designated Partner, since 29 Aug 2020).
Mahesh Sambhaji Jadhav was first appointed on 17 Dec 2019 as Director at Cliniva Pharmaceuticals Private Limited. The most recent appointment on record is 29 Aug 2020 at J3 Cure Pharmaceuticals Llp.
Mahesh Sambhaji Jadhav held 1 earlier board appointment: Cliniva Pharmaceuticals Private Limited (Director, 17 Dec 2019 to 30 Mar 2022).
The current boards of Mahesh Sambhaji Jadhav's companies include Prashant Govindbhai Desai (J3 Cure Pharmaceuticals Llp), Sushant Jayshing Jawak (J3 Cure Pharmaceuticals Llp).